/Companies

SiPhox Health

YC S20

Boston, US · Founded 2020 · Delaware corporation · 63 employees · Hiring · 22 known investors

Find your way into SiPhox Health

Sign up to see every warm intro you have to SiPhox Health

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the SiPhox Health team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Siphox Health develops early diagnostic testing technology to detect and manage chronic diseases at home, delivered as a painless 5-minute test that enables frequent monitoring. The company targets the U.S. healthcare system to reduce the health and economic burden of chronic disease.

Also known as SiPhox, Inc. · SiPhox · SiPhox Inc. · SiPhox Inc., SiPhox

Founders & leadership· Y Combinator alumni (S20)

SiPhox Health was founded in 2020 by Michael Dubrovsky and Diedrik Vermeulen.

MDMichael Dubrovsky
Michael DubrovskyCo-Founder and CEOCo-founder of SiPhox Health, which develops at-home diagnostic testing technology for chronic disease detection and monitoring.
DVDiedrik Vermeulen
Diedrik VermeulenCo-founder and CTOHe previously held roles as director of engineering at Analog Photonics and research scientist at MIT, with expertise in optical systems on chip design and chip-to-chip coupling.
PK
Pavel KoreckyHiring Admin
GB
George ButcherPrincipal Engineering Manager
NM
Nataly MizrahiDirector of Biomedical Integration
AM
Alexander MakarovCOO
DA
Dr. AliyaDirector of Clinical Product Operations
DKDaniel Kaplan
Daniel Kaplan
YG
Yaniv GoderVice President of Businessformer
JM
Jordan MoradianGrowth Leadformer
ES
Eric StepanskyHead of Businessformer
CF
Catherine FinkVice Presidentformer

Investors · 22

Intel Capitallisted by Intel CapitalSanta Clara · $1M – $20M

How we know: Intel Capital's portfolio page · a partner's Signal profile · funding news · company funding news (hacker news) · press coverage · Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · offering press articles · open dataset · 5k.vc investor directory · Not right? Tell us

Balaji Srinivasanreported$10K – $500K

How we know: deep research dossier: balaji-srinivasan · Not right? Tell us

Bantam GroupreportedWestwood

How we know: Y Combinator's founder network · Not right? Tell us

Coyote VenturesreportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

Elysium Venture CapitalreportedPalo Alto

How we know: Y Combinator's founder network · Not right? Tell us

Flashpoint Venture DebtreportedLondon

How we know: Y Combinator's founder network · Not right? Tell us

Khosla VenturesreportedMenlo Park · $100K – $20M

How we know: funding news · offering press articles · Y Combinator's founder network · Not right? Tell us

MetaplanetreportedTallinn · $500K – $10M

How we know: offering press articles · Y Combinator's founder network · Not right? Tell us

RsquaredreportedMclean

How we know: offering press articles · Not right? Tell us

Samsung NextreportedMountain View · $100K – $5M

How we know: Y Combinator's founder network · Not right? Tell us

Shorewind CapitalreportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

SP Investment Fundreported

How we know: Y Combinator's founder network · Not right? Tell us

Vituityreported

How we know: Y Combinator's founder network · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$15.1M disclosed across 4 rounds · 2020–2023

▶$12.5MraisedJan 2023 · 44 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael DubrovskyExecutive Officer, Director
  • Diedrik VermeulenExecutive Officer, Director
Offering amount
$15M
Amount sold
$12.5M
Proceeds to insiders
$294K
First sale
Jan 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedNov 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Diedrik VermeulenExecutive Officer, Director
  • Michael DubrovskyExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$1.5M
Proceeds to insiders
$150K
First sale
Nov 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10KraisedApr 2021 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael DubrovskyExecutive Officer
  • Diedrik VermeulenExecutive Officer, Director
Offering amount
$10K
Amount sold
$10K
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedDec 2020 · 19 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Diedrik VermeulenExecutive Officer, Director
  • Michael DubrovskyExecutive Officer
Offering amount
$2M
Amount sold
$1.1M
Proceeds to insiders
$280K
First sale
Aug 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 10

Vena VitalsVena Vitals develops a noninvasive, continuous blood pressure monitoring device using patented sensor technology placed on the skin over an artery. The system targets anesthesiologists, sleep physicians, and hospitals for intraoperative, sleep disorder, and clinical monitoring applications.
GTRACK TechnologiesGTRACK Technologies develops fluorescent nanoparticle tracers used to map subsurface fluid flow in geothermal and oil and gas reservoirs.
PreDxion BioPreDxion Bio develops rapid diagnostic tests using saliva samples and a scalable semiconductor-based platform, initially targeting SARS-CoV-2 detection for asymptomatic and presymptomatic individuals, with broader applications in monitoring immune response markers in critically ill patients and predicting complications from cell therapies.
AminoAnalyticaAmino Analytica designs rapid molecular diagnostic tests for emerging infectious diseases and biological threats, developed in weeks rather than the traditional 12+ months. The company combines point-of-care diagnostics technology with AI-driven bionanotechnology to enable earlier detection and faster pandemic response.
REPROSENTREPROSENT captures patient treatment experience data to support dose, safety, and development decisions in oncology and advanced cancer therapies. The platform operates as a lightweight, non-interventional overlay on existing clinical trials and care programs, converting patient symptoms into structured, computable signal for development and clinical teams.
UbieUbie provides a free AI-powered symptom checker that generates a personalized report on possible causes of a user's symptoms and guidance on when to see a doctor, based on a short questionnaire developed with doctors. The consumer-facing digital health service operates in Japan, the United States, and other countries.
Rupa HealthA platform that enables healthcare providers to order, track, and receive lab test results from multiple laboratory companies through a single dashboard, supporting both in-person and telehealth patients with flexible billing options and EHR integration.
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Mito HealthMito Health offers direct-to-consumer health testing and personalized diagnostics, allowing customers to order from 1000+ lab tests, scans, and health kits at transparent, cost-based pricing without requiring a doctor's referral. Members pay a $9/month subscription for access to member pricing, personalized action plans, longitudinal health tracking, and clinician-reviewed guidance through an AI health coach and concierge service.
SuperpowerSuperpower offers personalized health testing and monitoring for consumers, analyzing 100+ biomarkers across multiple body systems. The platform combines blood testing, data integration from wearables, AI-powered analysis, and access to clinical care teams to provide personalized health protocols and longevity guidance.

Companies working in the same space as SiPhox Health.

Legal entities · 1

corporate structure
SiPhox, Inc.

In the news

Frequently asked questions

What does SiPhox Health do?
Siphox Health develops early diagnostic testing technology to detect and manage chronic diseases at home, delivered as a painless 5-minute test that enables frequent monitoring. The company targets the U.S. healthcare system to reduce the health and economic burden of chronic disease.
Who founded SiPhox Health?
SiPhox Health was founded by Michael Dubrovsky, Diedrik Vermeulen in 2020.
Who are SiPhox Health's investors?
SiPhox Health's investors include Duke Capital Partners, Gaingels, Intel Capital, Koru Capital, LongeVC, Neer Venture Partners, Overlap Holdings, Y Combinator and 14 more.
How much funding has SiPhox Health raised?
SiPhox Health has disclosed $15.1M raised across 4 rounds.
Where is SiPhox Health headquartered?
SiPhox Health is headquartered in Boston, US.